Skip to main content
Premium Trial:

Request an Annual Quote

BioAnalytics Group Partners with Prescient to Develop Cardiovascular Diagnostics, Therapeutics

NEW YORK (GenomeWeb News) - The BioAnalytics Group said last week that it is collaborating with Prescient Medical to develop heart attack prevention and treatment technologies.
Under the agreement, the BioAnalytics Group will use its Model Based Assay biosimulation methodologies to help Prescient calibrate and optimize a Raman Spectroscopy-based diagnostic system to characterize vulnerable plaque.
The BioAnalytics Group also will provide statistical analysis support for the development of Prescient’s therapeutics product, particularly by helping design animal studies and human clinical trials.
The new collaboration extends a previous agreement between the companies.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.